FDA inspection
Infusyn Therapeutics: FDA inspection ending Nov 20, 2025
FDA inspection 1296662 · No Action Indicated (NAI) · Hackettstown, NJ
Key facts
| Inspection ID | 1296662 |
|---|---|
| Firm | Infusyn Therapeutics |
| FEI number | 3030198397 |
| Address | 121 Shelley Dr Ste 2h |
| City | Hackettstown |
| State | NJ |
| ZIP | 07840 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Nov 20, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data